Summary of Study ST002859
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001788. The data can be accessed directly via it's Project DOI: 10.21228/M8KX5C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST002859 |
| Study Title | Glucose tracing in vehicle- and Enzalutamide-treated 16D prostate cancer cells |
| Study Summary | In this study, we sought to determine how Enzalutamide treatment alters metabolism in 16D prostate cancer cells. |
| Institute | University of California, Los Angeles |
| Laboratory | Goldstein Lab |
| Last Name | Giafaglione |
| First Name | Jenna |
| Address | 610 Charles E Young Dr S, Los Angeles, CA, 90024, USA |
| jgiafaglione@g.ucla.edu | |
| Phone | 408-728-3065 |
| Submit Date | 2023-09-12 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Analysis Type Detail | GC-MS |
| Release Date | 2023-09-15 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | local_sample_id | Treatment |
|---|---|---|
| SA308958 | LTEnza-3 | 10uM Enzalutamide |
| SA308959 | LTEnza-2 | 10uM Enzalutamide |
| SA308960 | LTEnza-1 | 10uM Enzalutamide |
| SA308961 | Naive-2 | Vehicle (DMSO) |
| SA308962 | Naive-3 | Vehicle (DMSO) |
| SA308963 | Naive-1 | Vehicle (DMSO) |
| Showing results 1 to 6 of 6 |
